Clinical Research Facility
Kingsport, Tennessee 37660
We've found
16 trials
at this facility
Plaque Psoriasis Clinical Trial
Updated: 2/28/2014
A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Type II Diabetes Mellitus Clinical Trial
Updated: 12/29/2016
A Preliminary Study of the Efficacy and Safety of MK-8521 for Type 2 Diabetes (MK-8521-004)
Status: Enrolling,
Phase
II
Updated: 12/29/2016
Click here to add this to my saved trials
Diarrhoea Predominant Irritable Bowel Syndrome Clinical Trial
Updated: 8/1/2016
Retrospective Study of IBS-D Patients Previously Receiving SBI
Status: Enrolling
Updated: 8/1/2016
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Updated: 4/26/2017
One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 4/26/2017
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 2/2/2016
Safety and Efficacy Comparison Study of NK-104-CR (Controled Release) in Patients With Primary Hyperlipidemia or Mixed Dyslipidemia
Status: Enrolling,
Phase
III
Updated: 2/2/2016
Click here to add this to my saved trials
Macular Edema Clinical Trial
Updated: 3/2/2016
A Study in Participants With Neovascular Age Related Macular Degeneration or Macular Edema Secondary To Retinal Vein Occlusion to Evaluate Usability of the Lucentis® Prefilled Syringe
Status: Enrolling,
Phase
III
Updated: 3/2/2016
Click here to add this to my saved trials
Asthma Clinical Trial
Updated: 12/31/1969
Efficacy and Safety of PT001 to Placebo and Open-label Spiriva® Respimat® in Subjects With Persistant Asthma
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Asthma Clinical Trial
Updated: 12/31/1969
Efficacy and Safety of PT001 to Placebo and Open-label Spiriva® Respimat® in Subjects With Persistant Asthma
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
Updated: 10/22/2015
An Efficacy and Safety Trial of Verubecestat (MK-8931) in Mild to Moderate Alzheimer's Disease (P07738)
Status: Enrolling,
Phase
II, III
Updated: 10/22/2015
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Gastroenterology, Nephrology / Urology, Neurology Clinical Trial
Updated: 12/31/1969
Product Surveillance Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Kidney Disease Clinical Trial
Updated: 12/31/1969
A Study to Evaluate the Effect of Dapagliflozin on Renal Outcomes and Cardiovascular Mortality in Patients With Chronic Kidney Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Otolaryngology Clinical Trial
Updated: 12/31/1969
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 12/31/1969
The Product Surveillance Registry REVERSE Post Approval Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Psychiatry / Psychology Clinical Trial
Updated: 8/10/2016
Efficacy and Safety Trial of Verubecestat (MK-8931) in Participants With Prodromal Alzheimer's Disease (MK-8931-019)
Status: Enrolling,
Phase
III
Updated: 8/10/2016
Click here to add this to my saved trials
Immunology / Infectious Diseases, Pulmonary / Respiratory Diseases Clinical Trial
Updated: 4/22/2015
A Study to Evaluate the Safety, Tolerability and Immunogenicity of V114 in Healthy Adults and Infants (V114-004)
Status: Enrolling,
Phase
I, II
Updated: 4/22/2015
Click here to add this to my saved trials